IPRsonline.org
Resources
Education
Resources
Resources
Resources
Health 2007 2006 2005 2004 2003 2002 2001

Documents from 1995 to 2000 (click)

2007
Is Product Patent Protection Necessary in Developing Countries for Innovation? R&D by Indian Pharmaceutical Companies after TRIPS, September 2007.
Author: Professor Sudip Chaudhuri, Indian Institute of Management, Kolkata, India


Achieving Both Access and Research: A Sector Agreement in Pharmaceuticals
Author: John Barton

Expanding the Public Healthcare Architecture to help meet MDG: Proposals for the Long Term Funding and Management of a Pipeline of Essentail Medicines through Development and Distribution
Author: Peter Brown

Patents Without Monopolies
Author: Pablo Marion Challu

Fostering R&D and Promoting Access to Medicines
Author: Carlos Correa

Prize, Advanced Market Commitments, and Pharmaceuticals for Developing Countries

Author: Aidan Hollis

Operationalising Patent Pools for ARVs
Author: Warren Kaplan

The Right to Health: What Corporate Duties?
Author: Klaus M. Leisinger

The role of prizes in stimulating R&D: Comment to WHO IGWG
Author: James Love

IGWG Submission on Collective Management of Intellectual Property - The Use of Patent Pools to Expand Access to Needed Medical Technologies
Author: Manon Ress

Putting Health on the Fast Track: Compliance with the Doha Declaration on Public Health as a Principal Negotiating Objective for Trade Promotion Authority, August 2007.
Author: Margaret Lee, CIEL

Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices
, 2007.
MIHR and PIPRA


Facts and Evidences on The 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand
, February 2007.
Document explaining the Thai decision to use compulsory licenses, by the Ministry of Public Health and the National Health Security Office, Thailand

Guidelines for the examination of pharmaceutical patents: Developing a public health perspective, January 2007.
Author: Carlos Correa


2006
Report on Intellectual Property Rights, Innovation and Public Health, 2006.
CIPIH, WHO

The Use of Flexibilities in TRIPS by Developing Countries: Can they promote Access to Medicines?
Authors: Sisule. F. Musungu and Cecilia Oh

Protección de productos farmacéuticos y agroquímicos ('productos regulados') en DR-CAFTA
Author: Carlos M. Correa

The ability of select sub-Saharan African countries to utilise TRIPs Flexibilities and Competition Law to ensure a sustainable supply of essential medicines: A study of producing and importing countries.
Author: Tenu Avafia, Jonathan Berger and Trudi Hartzenberg

2005
Disembowelment of India’s Patent Regime, 2005.
Author: Dwijen Rangnekar, Centre for the Study of Globalisation and Regionalisation, University of Warwick, UK

Intellectual Property Quarterly Update, 2005.
Authors: South Centre and CIEL

Innovation in Developing Countries to meet health needs, experiencs of South Africa, Brazil, China and India
Country Reports for submission to the Commission on Intellectual Property Rights, Innovation and Public Health

WHO Commission on Intellectual Property Rights, Innovation and Public Health, 21 studies, 2005.
Authors: various

Struggling to Balance Free Trade with Access to Medicines in the post-TRIPS Era Throughout the Arab World
, 2005.
Author:
Othoman Mellouk, Association de Lutte Contre le Sida (ALCS), Marrakech

Protecting Test Data for Pharmaceutical and Agrochemical Products under Free Trade Agreements
, 2005.
Author: Carlos M. Correa, University of Buenos Aires

Undisclosed Clinical Trial Data under the TRIPS Agreement and its Progeny: A Broader Perspective
, 2005.
Author: Jerome H. Reichman, Duke University School of Law

Intellectual Property and Pharmaceutical Data Exclusivity in the Context of Innovation and Market Access
, 2005.
Author: Meir Perez Pugatch, University of Haifa

Health and Intellectual Property Rights: Thoughts on Ensuring Access to Medicines in 2005 and Beyond
, 2005
Author: Karin Timmermans, World Health Organization Indonesia.

Intellectual property and pharmanceutical data exclusivity in the context of innovation and market access
, 2005.
Author: Mair Perez Pugatch, University of Haifa

Product development partnerships on 'neglect diseases': How they handle intellectual property and how this may contribute to improving access access to pharmaceuticals for HIV/AIDS, TB and Malaria
, 2005.
Author: Roy Widdus, Global Forum for Research

Role, Perspectives and Challenges of the Generic Pharmaceutical Industry in Latin America
, 2005.
Author: Mirta Levis, Centro Industrial de Laboratorios Farmaceuticos Argentinos

Creating And Promoting Domestic Drug Manufacturing Capacities: Legal And Economic Feasibility Assessment
, 2005.
Author: Juan Rovira, University of Barcelona, Spain and SOIKOS.

Market Concentration Of The Transnational Pharmaceutical Industry And The Generic Industries In The World: Latest Trends on Mergers, Acquisitions and Other Transactions
, 2005.
Author: Barbara Rosenberg/ Ministry of Justice, Brazil.

2004
Dealmaking and Intellectual Property Management for Public Interest, 2004.
Author: Cathy Garner / IPPPH / MIHR


Access To Medicines And Drug Regulation In Developing Countries: A Resource Guide For DFID, 2004.
Authors: Andy Gray / Department for International Development Health Systems Resource Centre.

Access to Medicines in Under-served Markets: What are the implications of changes in intellectual property rights, trade and drug registration policy?, 2004.
Author: Health Systems Resource Centre, the Department for International Development.

Advancing public health by other means: Using competition policy to increase access to essential medicines, 2004.
Author: Jonathan Berger / UNCTAD-ICTSD.

Combating Diseases Associated with Poverty: Financing Strategies for Product Development and the Potential Role of Public-Private Partnerships, 2004.
Authors: Roy Widdus and Katherine White / The Initiative on Public-Private Partnerships for Health (IPPPH).

Creating And Promoting Domestic Drug Manufacturing Capacities: Legal And Economic Feasibility Assessment, 2004.
Author: Juan Rovira / UNCTAD-ICTSD.

Finding Cures for Tropical Diseases: Is Open Source an Answer? 2004,
Author: Stephen M. Maurer, Arti Rai and Andrej Sali

The FTA and the PBS - A submission to the Senate Select Committee on the US-Australia Free Trade Agreement, May 2004.
Author: Peter Drahos, Thomas Faunce, Martyn Goddard and David Henry.

How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries?
, March/April 2004.
Author: Amir Attaran, Health Affairs, Vol 23, Issue 3, 155-166.

Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Selected Low and Middle Income Countries A Synthesis Report from Studies in Botswana, Sri Lanka, Uganda and Zambia, 2004.
Authors: Karen Caines and Louisiana Lush / The Initiative on Public-Private Partnerships for Health (IPPPH).

Implementation of the Conevant on Civil and Political Rights in Uganda: Trade-related intellectual property rights, access to HIV/AIDS medicines and the fulfilment of civil and political rights, 2004.
Author: 3D.

La Aplicacion de la Convencion sobre los Derechos del Nino en El Salvador: La repercusión de los acuerdos comerciales internacionales por los que se rigen los derechos de propiedad intelectual en el acceso a los medicamentos y el respeto de los derechos del niño, 2004.
Author: 3D

Implementation of the Convention on the Rights of the Child in El Salvador: The impact of international trade agreements regulating intellectual property rights on access to medicines and the fulfillment of children's rights, 2004.
Author: 3D.

Implementation of the WTO General Council Decision on Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, April 2004.
Author: Carlos M. Correa, World Health Organization

Intellectual Property and Pharmaceutical Data Exclusivity in the Context of Innovation and Market Access, October 2004.
Author: Meir Perez Pugatch / UNCTAD-ICTSD.

La Applicacion de la Convencion sobre los Derechos del Niño en El Salvador: La repercusión de los acuerdos comerciales internacionales por los que se rigen los derechos de propiedad intelectual en el acceso a los medicamentos y el respeto de los derechos del niño, 2004.
Author: 3D-THREE.

Market Concentration Of The Transnational Pharmaceutical Industry And The Generic Industries In The World: Latest Trends on Mergers, Acquisitions and Other Transactions, 2004.
Author: Barbara Rosenberg / UNCTAD-ICTSD.

Ownership of Knowledge: the Role of Patents in Pharmaceutical R&D, October 2004.
Author: Carlos M. Correa, World Health Organization (WHO).

Patents, Trade and Health: How Strong Patent Protection Affects Access to Medicines Patents, Trade and Health, 2004.
Author: Jonathan Hepburn / Quaker International Affairs Programme, Ottawa and Quaker United Nations Office, Geneva.

Processes and Issues for Improving Access to Medicines: Willingness and Ability to Utilise TRIPS Flexibilities in Non-Producing Countries, 2004.
Authors: Brook K. Baker / Health Systems Resource Centre, the Department for International Development.

Product Development Partnerships on 'Neglected Diseases': How they Handle Intellectual Property and how this may Contribute to Improving Access to Pharmaceuticals for HIV/AIDS, TB and Malaria
, October 2004.
Author: Roy Widdus / UNCTAD-ICTSD.

Protecting Test Data for Pharmaceutical and Agrochemical Products under Free Trade Agreements, 2004.
Author: Carlos M. Correa/ UNCTAD-ICTSD.

Public-Private Management of Intellectual Property for Public Health Outcomes in the Developing World The Lessons of Access Conditions in Research and Development Agreements, 2004.
Authors: Antony Taubman / The Initiative on Public-Private Partnerships for Health (IPPPH).

Public Goods and the public domain: the access to konwledge in developing countries, and innovation in health, education and science, 2004.
Author: Clemente Forero Pineda / UNCTAD-ICTSD.

Role, Perspectives and Challenges of the Generic Pharmaceutical Industry in Latin America, 2004.
Author: Mirta Levis / UNCTAD-ICTSD.

The Cycle of Action and Reaction: Latest Developments and Trends in IP and Health, October 2004.
Author: Frederick Abbott / UNCTAD-ICTSD.

The Doha Declaration on the TRIPS Agreement and Public Health and the Contradictory Trend in Bilateral and Regional Free Trade Agreements, 2004.
Author: Frederick Abbott / Quaker United Nations Office.

The Effect of Changing Intellectual Property on Pharmaceutical Industry Prospects in India and China:Considerations for Access to Medicines, 2004.
Authors: Cheri Grace / Health Systems Resource Centre, the Department for International Development.

Utilizing TRIPS Flexibilities for Public Health Protecton Through South-South Regional Frameworks, 2004.
Authors: Sisule F. Musungu, Susan Villanueva, Roxana Blasetti / South Centre.

Health and Intellectual Property Rights: Thoughts on Ensuring Access to Medicines in 2005 and Beyond
Author: Karin Timmermans, World Health Organization Indonesia.

2003
Accès aux génériques et propriété intellectuelle, 2003.
Author: Act Up Paris.

An Agenda for Research and Development: Meeting on the Role of Generics and Local Industry in Attaining the Millenium Development Goals (MDGS) in Pharmaceuticals and Vaccines, 2003.
Author: J. Love, T. Hubbard / Consumer Project on Technology (CPTech) - Health Care and Intellectual Property (2003).

Application of Methods related to Medical Activity to the Patent Law, 2003.
Author: Patent System Subcommittee, Intellectual Property Policy Committee, Industrial Structure Council, Japan.

Bioethical Issues of IPRs. Theme 5: Practical Implications for Healthcare, Access to Essential Medicines and Patents Holders, 2003.
Author: Richard Ashcroft (Imperial College, London).

Can 'The Spirit of Doha' be Kept Alive?, 2003.
Author: D. Dickson / SciDev.Net.

Derechos de propiedad intelectual, innovación y salud pública, 2003.
Author: Informe de la Secretaría, Organizacion Mundial de la Salud.

Droits de propriété intellectuelle, innovation et santé publique, 2003.
Author: Rapport du Secrétariat, Organisation Mondiale de la Santé.

Droits de propriété intellectuelle, innovation et santé publique. Résolution de l'Assemblé Mondiale de la Santé , 2003.
Author: Cinquante-Sixième Assemblé Mondiale de la Santé, 28 mai 2003.

From TRIPS to RIPS: A better Trade Framework to support Innovation in Medical Technologies, 2003.
Author: James Love / Agence nationale de recherches sur le sida/Institute d' économie publique, Workshop on Economic issues related to access to HIV/AIDS care in developing countries, 27 May 2003.

FTAA: Protectionism for US Drug Industry. Affordable AIDS Medicine Denied in Latin America, 2003.
Author: Health GAP (Global Access Project) / briefing document.

Implementing the Doha Mandate on TRIPS and Public Health, 2003.
Author: Fink C. / International Trade Department, World Bank.

Intellectual Property Rights (IPRs) and Genetics: A Study into the Impact and Management of Intellectual Property Rights within the Healthcare Sector, 2003.
Authors: Professor W. R. Cornish, Dr M. Llewelyn, Dr M. Adcock.

Intellectual Property Rights, Innovation and Public Health, 2003
Author: Report by the Secretariat / World Health Organization, 12 May

Interpreting Para 6, Deal on Patents and Access to Drugs, 2003.
Author: K. Ravi Srinivas / The Economic and Political Weekly, Mumbai.

L'accord sur les droits de propriété intellectuelle et la santé publique, 2003.
Author: Raoul Marc Jennar / Démocratie et Socialisme, 4 septembre.

Medecine Prices, A New Approach to Measurement, 2003.
Author: Working draft for field testing and revision, World Health Organization and Health Action International.

Open Letter Concerning Intellectual Property and Access to Medicines in The US-Central American Free Trade Agreement (CAFTA), 2003.
Author: Médecins sans Frontières (MSF).

Out-licensing: a practical approach for improvement of access to medicines in poor countries, 2003.
Authors: Michael A Friedman, Henk den Besten, Amir Attaran / THE LANCET, Vol. 361.

Public Health Versus Intellectual Property
, 2003.
Author: Servaas van Thiel

Tratado Internacional de Propiedad Intelectual, 2003.
Author: Carlos Correa / Observatorio de Salud, Medicamentos y Sociedad, Argentina.

The Impact of WTO Agreements on Health and Development Policies, 2003.
Author: Meri Koivusalo / Globalism and Social Policy Programme.

TRIPS, Drug Patents and Access to Medicines-Balancing Incentives for R&D with Public Health Concerns, 2003.
Author: Prof. Keith Maskus / Development Gateway Expert Perspective: 4 September 2003.

Simulation to the 5th Ministerial Conference of the World Trade Organization on " The TRIPS Agreement & its Implications on Public Health", 2003. Background document on this topic: The World Trade Organization "The 5th Ministerial Conference", TRIPS Agreement, Public Health a Challenging Battle.
Author: Rami I. El-Dokany, Faculty of Economics & Political Science, Cairo University, Egypt (the main paper contains the decisions and recommendations adopted from this simulation by the Faculty).

Valuing Industry Contributions to Public-Private Partnerships for Health Product Development, 2003.
Authors: Hannah Kettler, Karen White and Scott Jordan / Initiative on Public-Private Partnerships for Health.

Working document on developing countries’ duties and taxes on essential medicines used in the treatment of the major communicable diseases, 2003.
Author: Directorate-General for Trade, European Commission.

2002
Access to Essential Drugs may be Undermined by Global Patent Agreement, 2002.
Author: Cooperation South Journal, United Nations Development Programme, p.125-127.

Access to Medicines and Public Policy Safeguards under TRIPS, 2002
Author: Dr. K. Balasubrarnaniam / Health Action International Asia Pacific.

Access to Medicines For All: A Major Human Rights Issue, 2002.
Author: Narenda B. Zaveri / BRIDGES, ICTSD, Vol. 6, N°5, June 2002.

Access to Medicines: Solving the Export Problem under TRIPS, 2002.
Author: James Love / BRIDGES, ICTSD, Vol. 6, N°4, May 2002.

Access to Medicines: WTO Members May Snatch Defeat out the of Jaws of Victory, 2002.
Author: Editorial / BRIDGES, ICTSD, Vol.6, N°8, November-December 2002.

Amended Patents Act and Access to Medicines after Doha, 2002.
Author: P. Cullet / Economic and Political Weekly XXXVII/24, 15 June 2002, p. 2278.

Anthrax, Drug Transnationals, and TRIPS, 2002.
Author: K. Singh / Foreign Policy in Focus (FPIF), edited by John Gershman, 29 April 2002.

Arguments: Access to Healthcare and IPRs — The Normative Issues, 2002.
Author: Rainer Döbert / 8th Circular: Part Two: Access to Health Care and IPRs — The Normative Issues, IPR Dialogue Working Group III (Access to Essential Medicines).

Balancing Health Needs and Drug Research Incentives, 2002.
Authors: Hannah H. Kettler, Chris Collins / Cooperation South Journal - 2002, United Nations Development Programme, p.10-36.

Beyond TRIPS: A New Global Patent Regime, 2002.
Author: J. Olson Lanjouw / Center for Global Development Brief, Vol.1, Issue N°3.

Bio-Pharmaceuticals and Health, 2002.
Author: UNU/INTECH / Technology Policy Briefs, Vol.1, Issue N°3.

Biopharmaceutiques et santé - résumé, 2002.
Author: UNU/INTECH / Synthèse sur les Politiques Technologiques, Vol. 1, N°3.

Compulsory Licensing for Public Health Needs: The TRIPS Agenda at the WTO after the Doha Declaration on Public Health, 2002.
Author: F.M. Abbott / Occasional Paper 9, Quaker United Nations Office (QUNO).

Historic Doha Declaration on the TRIPS Agreement and Public Health, 2002.
Author: Department of Essential Drugs and Medicines Policy, WHO / Essential Drugs in Brief, Issue N°6, April 2002.

Impact of Patents on Access to HIV/AIDS Drugs in Developing Countries, 2002.
Authors: J-R. Borrell, J. Watal / CID Working Paper, N°92.

Implications of the Doha Declaration on the TRIPS Agreement and Public Health, 2002.
Authors: Carlos M. Correa / WHO Health Economics and Drugs, EDM Series, N°12. CID Working Paper, N°92.

Intellectual property and the availability of pharmaceuticals in poor countries, 2002.
Author: J. Olson Lanjouw / Forthcoming in: Innovation Policy and the Economy, National Bureau of Economic Research (NBER), Vol. 3, 23 April 2002.

Intellectual Property Rights in Biotechnology and Health Care — Results of a Stakeholder Dialogue, 2002.
Author: World Business Council for Sustainable Development (ed.), Wissenschaftzentrum Berlin für Sozialforschung.

International IP issues Post-Doha: Geographical Indications, Access to Medicines, Biotechnology and other current issues, 2002.
Author: Briefing chaired by Professor Andrew Christie, Intellectual Property Research Institute of Australia, Speakers: David Hallett and Peter Lawrence / Foreign Affairs and Trade, Office of Trade Negociations, Australia.

Introducing patent protection in the pharmaceutical sector : a first evaluation for the Mexican case, 2002.
Authors: Emmanuel Combe, Pluvia Zuniga.

Issues related to Access to Essential Medicines, 2002.
Author: "Stakeholder Dialogue Process on the Issues of Intellectual Property Rights in Biotechnology" organised by WISSENSCHAFTSZENTRUM BERLIN FÜR SOZIALFORSCHUNG and World Business Council for Sustainable Development.

L'accès des pays pauvres aux médicaments, 2002.
Author: Paul Benkimoun / Le Monde, 24.05.2002.

Le commerce et la santé : priorité à l'accès aux médicaments essentiels, 2002.
Authors: Gauri Sreenivasan et Ricardo Grinspun / Mondialisation du commerce – Mondialisation de la pauvreté, Les enjeux pour le Canada : perspectives des ONG, Conseil canadien pour la coopération internationale, Série sur le commerce et la pauvreté, Article 4.

Legal Options for Implementing Paragraph 6 of the Ministerial Declaration on the TRIPS Agreement and Public Health, 2002.
Author: M.C.E.J Bronckers / Summary of Oral Presentation at Quaker United Nations Office (QUNO) – Norway Ministry of Foreign Affairs Meeting at Utstein Monastery, Norway, July 20-23, 2002

Legal Options for Implementing Paragraph 6 of the Ministerial Declaration on the TRIPS Agreement and Public Health, 2002.
Author: Frederick M. Abbott / Summary of Oral Presentation at Quaker United Nations Office (QUNO) – Norway Ministry of Foreign Affairs, Meeting at Utstein Monastery, Norway, July 20-23, 2002.

Medicina tradicional, patentes y biopiratería, 2002.
Author: Silvia Ribeiro / La Jornada, México.

Patents and Drug Prices, 2002.
Authors: World Business Council for Sustainable Development and Wissenschaftzentrum Berlin für Sozialforschung.

Patents, International Trade Law and Access to Essential Medicines, 2002.
Authors: Richard Elliot, Marie-Hélène Bonin / Canadian HIV/AIDS Legal Network & Médecins Sans Frontières Canada.

Patents, Pills and Public Health: Can TRIPS Deliver? 2002.
Author: Martin Foreman / The Panos Institute.

Pricing Medicines to Benefit Poor Countries, 2002.
Author: Jagdish Bhagwati / Cooperation South Journal - 2002, United Nations Development Programme, p.37-39.

Promoting Good Ideas on Drugs: Are Patents the Best Way? The Relative Efficiency of Patent and Public Support for Bio-Medical Research, 2002.
Authors: Dean Baker and Noriko Chatani / Center for Economic and Policy Research, Briefing Paper.

Proteccion de los Datos Presentados para el Registro de Productos Farmacéuticos. Implementacion de las Normas del Acuerdo TRIPS, 2002.
Author: C. Correa / South Centre.

Protection and Promotion of Traditional Medicine: Implications for Public Health in Developing Countries, 2002.
Author: C. Correa / South Centre.

Protection of Data Submitted for the Registration of Pharmaceuticals: Implementing the Standards of the TRIPS Agreement, 2002.
Author: C. Correa / South Centre.

Reshaping the TRIPS Agreement concerning Public Health: Two Critical Issues, 2002.
Author: H. Sun.

Sobredosis de ganancias, 2002.
Author: Silvia Ribeiro / La Jornada, México.

Stakeholder Dialogue Process on the Issues of Intellectual Property Rights in Biotechnology: Issues related to Access to Essential Medicines and to Access to Human Genetic Resources, 2002.
Author: (Dialogue organised by the World Business Council for Sustainable Development and Wissenschaftzentrum Berlin für Socialforschung).

Summary report on the Conference of the Commission on Intellectual Property Rights, 2002.
Author: International Institute for Sustainable Development (IISD).

The Doha Agenda and Intellectual Property Rights, 2002.
Author: Phillip McCalman / prepared under the Asian Development Bank’s (ADB) Regional Technical Assistance 5994: A Study on Regional Integration and Trade: Emerging Policy Issues for Selected Developing Member Countries.

The FTAA, access to HIV/AIDS treatment, and human rights, 2002.
Author: Human Rights Watch / A Human Rights Watch Briefing Paper, 29 October 2002.

The Role of Intellectual Property and Licensing in Promoting Research in International Health: Perspectives from a Public Sector Biomedical Research Agency, 2002.
Authors: Gerald T. Keusch, Rachel A. Nugent / CMH Working Paper Series, Commission on Macroeconomics and Health, Paper N°WG2 : 6.

The WTO TRIPS Agreement and the Protection of Public Health: Implementing paragraph 6 of the Doha Declaration, 2002.
Author: Utstein Kloster / Report on the workshop organized by the Quaker United Nations Office (QUNO) and the Ministry of Foreign Affairs, Norway.

Trade and Health: Focus on Access to Essential Medicines, 2002.
Authors: Gauri Sreenivasan, Ricardo Grinspun / Global Trade/Global Poverty, NGO Perspectives on Key Challenges for Canada, Canadian Council for International Co-operation, Trade and Poverty Series, Paper N°4.

Trasnacionales farmacéuticas contra la salud, 2002.
Author: Silvia Ribeiro / La Jornada, México.

TRIPS and Non-violation Complaints: From a Public Health Perspective, 2002.
Author: Haochen Sun / Centre for WTO Studies.

TRIPS and Pharmaceutical Industry: Issues and Prospects, 2002.
Author: N. Lalitha.

TRIPS and public health: the next battle, 2002.
Author: Oxfam / Oxfam Briefing Paper, N°15.

TRIPS, Intellectual Property Rights and Access to Medicines, 2002.
Author: World Health Organization (WHO) / HIV/AIDS Antiretroviral Newsletter, December 2002, Issue N°8.

Report to the Prime Minister - UK Working Group on Increasing Access to Essential Medicines in the Developing World: Policy Recommendations and Strategies, 2002.
Author: Clare Short / Departement for International Development (DFID).

US bullying on drug patents: one year after Doha, 2002.
Author: Oxfam / Oxfam Briefing Paper, N°33.

Using Innovative Action to Meet Global Health Needs through Existing Intellectual Property Regimes, 2002.
Authors: Hannah E. Kettler, Chris Collins / Study Paper 2b, UK Commission on Intellectual Property Rights.

WTO TRIPS Agreement and Its Implications for Access to Medicines in Developing Countries, 2002.
Author: F.M. Abbott / Study Paper 2a, UK Commission on Intellectual Property Rights.

2001
Accessing ARVs: untangling the web of price reductions for Developing Countries, 2001.
Authors: C. Perez-Casas, C. Macé, D. Berman, J. Double / Access to Essential Medicines Campaign, MSF.

Access to Medicines Could Become Doha’s (only?) Success Story, 2001.
Author: Editorial / BRIDGES, ICTSD, Vol. 5, N°5, June 2001.

Accord sur les Aspects des Droits de Propriété Intellectuelle liés au Commerce: l'Accès aux Médicaments entre Intérêts Privés et Biens Publics, 2001.
Author: Solagral / Réunion organisé par Solagral dans le cadre du programme "Du citoyen à l'OMC".

A Matter Of Life And Death: The Role Of Patents In Access To Essential Medicines, 2001.
Author: Médecins Sans Frontières (MSF).

A patent policy proposal for global diseases, 2001.
Author: J. Olson Lanjouw / Policy Brief, The Brookings Institution, N°84.

A Proposal to Use Patent Law to Lower Drug Prices in Developing Countries, 2001.
Author: J. Olson Lanjouw / Commission on Macroeconomics and Health CMH Working Paper Series Paper N°WG2: 11.

Are patent rules compatible with access to essential medicines in developing countries ?, 2001.
Author: G. Dutfield / SciDev.Net.

Communication from the European Communities and their Member States to the TRIPS council: the relationship between provisions of the TRIPS Agreement and access to medicines, 2001.
Author: European Commission.

Construing Intellectual Property Rights and Competition Policy Consistently with Facilitating Access to Affordable AIDS Drugs to Low-End Consumers, 2001.
Author: James Thuo Gathii / Florida Law Review, Vol 53, N°4.

Consumption and trade in off-patented medicines, 2001.
Author: H.E. Bale / Working Paper, Indian Council for Research on International Economic Relations (ICRIER), N°65.

Dare to lead: public health and company wealth, 2001.
Author: Oxfam / Oxfam Briefing Paper on GlaxoSmithKline.

Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents, 2001.
Author: Patricia M. Danzon / Commission on Macroeconomics and Health CMH Working Paper Series, N°WG2 : 10.

Differentiated pricing of patented products, 2001.
Author: J.H. Barton / CMH Working Paper Series, Commission on Macroeconomics and Health, Paper N°WG4 : 2.

Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?, 2001.
Authors: L. Gillespie-White, A. Attaran / JAMA Special Communication, American Medical Association, Vol. 286, N°15.

Draft Declaration on the TRIPS Agreement and Public Health, 12.11.2001.
Author: WTO.

Drug companies vs. Brazil: the threat to public health, 2001.
Author: Oxfam / Oxfam GB Briefing Paper.

Fatal imbalance: the crisis in research and development for drugs for neglected diseases, 2001.
Authors: the MSF Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group.

Fatal Side Effects: Medicine Patents under the Microscope, 2001.
Authors: M. Bailey, R. Mayne, Dr M. Smith / Oxfam GB.

Formula for fairness: patient rights before patent rights, 2001.
Author: Oxfam / Oxfam Company Briefing Paper on Pfizer, N°1.

Generic Drugs, Compulsory Licensing and Other Intellectual Property: Tools for Improving Access to Medicine, 2001.
Author: M.A. Gollin / Occasional Paper 3, Quaker United Nations Office (QUNO).

Generic Exploring the Hidden Costs of Patents, 2001.
Author: S. Macdonald / Occasional Paper 4, Quaker United Nations Office (QUNO).

Globalization, patents and drugs: an annotated bibliography, 2001.
Author: WHO Essential Drugs and Medicines Policy / Health Economics and Drugs, EDM Series, N°10.

Globalization, TRIPS and Access to Medicines, 2001
Author: Dr Gro Harlem Brundtland, WHO / Statement on the occasion of the 4th WTO Ministerial Conference, Doha, Qatar, 9 to 13 November 2001.

Globalization, TRIPS and Access to Pharmaceuticals, 2001
Author: WHO / WHO Policy Perspectives on Medicines.

Health and intellectual property rights, 2001.
Author: Carlos M. Correa / Editorial, Bulletin of the World Health Organization (WHO), Vol. 79, N°5.

Implausible denial: why the drug giants' arguments on patents don't stack up, 2001.
Author: Oxfam / Oxfam Policy Papers, April 2001.

Intellectual property and the knowledge gap, 2001.
Author: Oxfam / Oxfam Discussion Paper, December 2001.

Intellectual property rights in the global economy, 2001.
Author: K. Maskus / Institute for International Economics.

Integrando la Salud Publica en la Legislacion sobre Patentes de los Paises en Desarrollo, 2001.
Author: Carlos M. Correa / South Centre.

Intégration des Considérations de Santé Publique dans la Législation en matière de Brevets des Pays en Développement, 2001.
Author: Carlos M. Correa / South Centre.

La globalización, el Acuerdo sobre los ADPIC y el acceso a los productos farmacéuticos, 2001.
Author: OMS/ Perspectivas Politicas sobre Medicamentos de la OMS.

Médicaments : assouplissement des brevets, 2001.
Author: Alpha Barry / Survivre au Sida.

Mondialisation, ADPIC et accès aux produits pharmaceutiques, 2001.
Author: OMS/ Perspectives Politiques de l'OMS sur les Médicaments .

More Equitable Pricing for Essential Drugs: What do we mean and what are the issues?, 2001.
Author: Background paper for the WHO-WTO secretariat workshop on differential pricing and financing of essential drugs, Høsbjør, Norway, 8-11 April.

Network for Monitoring the Impact of Globalization and TRIPS on Access to Medicines, 2001.
Author: WHO Meeting Report, 19-21 February 2001, Chulalongkorn University, Bangkok, Thailand.

Parallel Imports of Pharmaceutical Products in the European Union, 2001.
Authors: M. Ganslandt, K. Maskus.

Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries, 2001.
Author: Keith E. Maskus / Final Report to World Intellectual Property Organization under terms of Special Service Agreement.

Parallel Trade - the case on Pharmaceuticals, 2001.
Author: Ki-Huen Kwok / International Economic Relations.

Patent Injustice: How World Trade Rules Threaten the Health of Poor People, 2001.
Author: Oxfam / Oxfam’s Cut the Cost campaign.

Patent Law, TRIPS, and R&D Incentives: A Southern Perspective, 2001.
Author: Carlos M. Correa / CMH Working Paper Series, Commission on Macroeconomics and Health, Paper N°WG2: 12.

Patents in Genomics and Basic Research: Issues for Global Health, 2001.
Author: John Barton / CMH Working Paper Series, Commission on Macroeconomics and Health, Paper N°WG2: 12.

Pills and Pocketbooks: Equity Pricing of Essential Medicines in Developing Countries, 2001.
Author: E. Hoen 't / Médecins Sans Frontières (MSF), MSF Campaign for Access to Essential Medicines.

Post-TRIPS options for access to patented medicines in developing countries, 2001.
Authors: F.M. Scherer, J. Watal / CMH Working Paper Series, Commission on Macroeconomics and Health, Paper N°WG41.

Priced out of Reach: How WTO patent policies will reduce access to medicines in the developing world, 2001.
Author: Oxfam / Oxfam Briefing Paper, N°4.

Protection of Traditional Medicine, 2001.
Author: Richard Wilder / CMH Working Paper Series, Commission on Macroeconomics and Health, Paper N°WG 4: 4.

Public-Private research for health, 2001.
Authors: V. Lehmann, G. Walt, L. Lush, B. Levings, P. Kahn, R. Harbinson, N. Louwaars, M. Minderhoud, P. Mulvany, D. Rangnekar, L. Pettiford, G. Frempong, E. Torreele / Biotechnology and Development Monitor, N°46.

Report of the workshop on differential pricing and financing of essential drugs, 2001.
Author: World Health Organization and World Trade Organization Secretariats.

Responding to market failures in tuberculosis control, 2001.
Authors: Rajesh Gupta, Jim Y. Kim, Marcos A. Espinal, Jean-Michel Caudron, Bernard Pecoul, Paul E. Farmer, Mario C. Raviglione / Sciencexpress, Policy Forum, 19 July 2001.

Santé & Propriété Intellectuelle, 2001.
Author: Gumisai Mutume / Afrique Relance, La lutte contre le Sida en Afrique, Vol. 15, N°1.

Some Assumptions on Patent Law and Pharmaceutical R&D, 2001.
Author: C. Correa / Occasional Paper 6, Quaker United Nations Office (QUNO).

South Africa vs. the Drug Giants A Challenge to Affordable Medicines, 2001.
Author: Oxfam / Oxfam Background Briefing, February 01.

The chemical industry comments on a possible new round & TRIPs, 2001.
Author: European Chemical Industry Council.

The Declaration on TRIPS and Public Health: A Step in the Right Direction, 2001.
Author: Ellen't Hoen / BRIDGES, ICTSD, Vol. 5, N°9, November-December 2001.

The global AIDS crisis and the first 100 days of George W. Bush's Administration: a report card from the health gap coalition, 2001.
Author: Health GAP Coalition / Global Treatment Access Campaign (GTAC).

The Role of Intellectual Property and Licensing in Promoting Research in International Health: Perspectives from a Public Sector Biomedical Research Agency, 2001.
Authors: Gerald T. Keusch, Rachel A. Nugent / Commission on Macroeconomics and Health (CMH) Working Paper Series, N°WG2 : 7.

The TRIPS Agreement, Access to Medicines, and the Doha Ministerial Conference, 2001.
Author: F.M. Abbott / Occasional Paper 7, Quaker United Nations Office (QUNO).

TRIPS and Health Emergencies, 2001.
Author: United States Trade Representative / USTR Background Paper, 10 November 2001.

TRIPS and Public Health, Opportunities for Doha, 2001.
Author: E. Herfkens / BRIDGES, ICTSD, Vol. 5, N°8, October 2001.

TRIPS and Public Health vs TRIPs and Pandemics?, 2001.
Author: Editorial / BRIDGES, ICTSD, Vol. 5, N°8, September 2001.

TRIPS and R&D Incentives in the Pharmaceutical Sector, 2001.
Author: Carlos M. Correa / CMH Working Paper Series, Commission on Macroeconomics and Health, Paper N°WG2: 11.

TRIPS and Rights: International Human Rights Law, Access to Medicines, and the Interpretation of the WTO Agreement on Trade-Related Aspects on Intellectual Property, 2001.
Author: Richard Elliott / The Canadian HIV/AIDS Legal Network, AIDS Law Project South Africa.

TRIPS Disputes: Implications for the Pharmaceutical Sector , 2001.
Author: C. Correa / Occasional Paper 5, Quaker United Nations Office (QUNO).

What did Doha accomplish?, 2001.
Author: L. Gillespie-White / International Intellectual Property Institute (IIPI).

WHO-WTO Workshop on Differential Pricing and Financing of Essential Drugs, 8-11 April, 2001.
Author: Jayashree Watal.

WHO-WTO Workshop on Differential Pricing and Financing of Essential Drugs, Executive Summary of Report, 8-11 April, 2001.
Author: World Health Organization (WHO) and World Trade Organization Secretariats (WTO).

Workshop on Differential Pricing and Financing of Essential Drugs: Session V - Market Segmentation: techniques, actors and incentives - The use of intellectual property rights, 2001. Executive Summary of report
Author: Richard Wilder / workshop organised by the World Health Organization and World Trade Organization Secretariats
8-11 April 2001, Høsbjør, Norway.

WTO patent rules and access to medicines: the pressure mounts, 2001.
Author: Oxfam / Oxfam GB Background Briefing, June 2001.

© ICTSD 2004 - Last Update: 05-Oct-2009